Pierre Labauge Selected Research

Pierre Labauge Research Topics

Disease

32	Multiple Sclerosis 03/2024 - 04/2012
13	Leukoencephalopathies 01/2022 - 06/2003
7	Relapsing-Remitting Multiple Sclerosis 01/2023 - 02/2016
6	COVID-19 01/2024 - 01/2020
5	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 08/2013
5	Neuromyelitis Optica (Devic's Disease) 01/2022 - 09/2017
5	Progressive Multifocal Leukoencephalopathy 01/2021 - 12/2016
5	Inflammation (Inflammations) 01/2021 - 08/2011
4	Disease Progression 06/2023 - 01/2007
4	Infections 01/2022 - 10/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 10/2010
4	Ataxia (Dyssynergia) 06/2017 - 02/2008
3	Chronic Progressive Multiple Sclerosis 01/2023 - 01/2017
3	Transverse Myelitis (Necrotizing Myelitis) 01/2023 - 10/2015
2	Central Nervous System Cavernous Hemangioma 05/2024 - 06/2006
2	Obesity 01/2024 - 10/2021
2	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 10/2013
2	Stroke (Strokes) 01/2023 - 12/2017
2	Vasculitis (Vasculitides) 01/2023 - 01/2011
2	Lymphoma (Lymphomas) 01/2019 - 03/2016
2	recessive Spastic paraplegia type 5A 01/2018 - 03/2015
2	Optic Neuritis (Retrobulbar Neuritis) 01/2018 - 10/2017
2	Polyneuropathies (Polyneuropathy) 07/2017 - 02/2008
2	Cerebellar Ataxia (Dysmetria) 06/2017 - 03/2015
2	Atrophy 05/2017 - 08/2009
2	Myelitis 08/2012 - 01/2012
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 10/2010 - 10/2008
2	Neoplasms (Cancer) 03/2010 - 02/2007
2	beta-Mannosidosis (beta-Mannosidase Deficiency) 09/2009 - 01/2009
1	cell-associated neurotoxicity 01/2023
1	Cytokine Release Syndrome 01/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2023
1	Hyponatremia 01/2023
1	Meningitis 01/2023
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2023
1	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2023
1	Radiculopathy (Radiculopathy, Cervical) 01/2023
1	Histiocytosis 01/2023
1	POEMS Syndrome (Syndrome, POEMS) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Systemic Vasculitis 01/2023
1	Neuroinflammatory Diseases 10/2022
1	Leukocytosis (Pleocytosis) 10/2021
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2021
1	Glioma (Gliomas) 10/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Uveitis 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Headache (Headaches) 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2010
9	Natalizumab (Tysabri)FDA Link 01/2022 - 02/2016
9	AntibodiesIBA 01/2022 - 02/2007
7	SteroidsIBA 01/2021 - 08/2011
6	GadoliniumIBA 01/2023 - 01/2012
5	Biotin (Vitamin H)FDA Link 01/2021 - 11/2016
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 02/2016
4	Oligoclonal BandsIBA 10/2021 - 01/2012
3	nitazoxanide (NTZ)FDA Link 01/2022 - 08/2017
3	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 08/2009 - 06/2003
2	teriflunomideIBA 10/2023 - 01/2019
2	Glial Fibrillary Acidic ProteinIBA 01/2023 - 01/2020
2	ocrelizumabIBA 01/2023 - 12/2022
2	Monoclonal AntibodiesIBA 01/2023 - 12/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2021
2	Amyloid (Amyloid Fibrils)IBA 12/2022 - 10/2020
2	AutoantibodiesIBA 10/2022 - 07/2017
2	Myelin-Oligodendrocyte GlycoproteinIBA 10/2021 - 04/2020
2	InterferonsIBA 01/2021 - 07/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2019 - 01/2017
2	Rituximab (Mabthera)FDA Link 01/2019 - 01/2017
2	IronIBA 03/2015 - 08/2009
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2012 - 10/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 03/2010 - 01/2007
2	beta-MannosidaseIBA 09/2009 - 01/2009
1	Complementary DNA (cDNA)IBA 05/2024
1	Chimeric Antigen ReceptorsIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	adenylate kinase 5IBA 10/2021
1	Leucine (L-Leucine)FDA Link 10/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Peptides (Polypeptides)IBA 10/2020
1	Amyloid beta-PeptidesIBA 10/2020
1	amyloid beta-protein (1-40)IBA 10/2020
1	Aquaporins (Water Channels)IBA 04/2020
1	Abatacept (Orencia)FDA Link 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2019
1	Methotrexate (Mexate)FDA LinkGeneric 07/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019

Therapy/Procedure

23	Therapeutics 03/2024 - 01/2017
2	Stem Cell Transplantation 12/2019 - 01/2019
1	Immunotherapy 10/2021
1	Artificial Respiration (Mechanical Ventilation) 10/2021
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019
1	Hematopoietic Stem Cell Transplantation 01/2019